The heart in Anderson-Fabry disease and other lysosomal storage disorders
- PMID: 17401074
- PMCID: PMC1861503
- DOI: 10.1136/hrt.2005.063818
The heart in Anderson-Fabry disease and other lysosomal storage disorders
Conflict of interest statement
In compliance with EBAC/EACCME guidelines, all authors participating in Education in
References
-
- Mehta A, Ricci R, Widmer U.et al Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey. Eur J Clin Invest 200434236–242.Analysis of the largest ever published dataset of Anderson‐Fabry disease patients. Comprehensive overview of disease key manifestations, prevalence and significance. - PubMed
-
- Nakao S, Takenaka T, Maeda M.et al An atypical variant of Fabry's disease in men with left ventricular hypertrophy. N Engl J Med 1995333288–293.First large study analysing the prevalence of Anderson‐Fabry disease among patients with unexplained cardiac hypertrophy. - PubMed
-
- Sachdev B, Takenaka T, Teraguchi H.et al Prevalence of Anderson‐Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation 20021051407–1411.Key study indicating larger prevalence of Anderson‐Fabry disease among patients with late onset hypertrophic cardiomyopathy. - PubMed
-
- Chimenti C, Pieroni M, Morgante E.et al Prevalence of Fabry disease in female patients with late‐onset hypertrophic cardiomyopathy. Circulation 20041101047–1053. - PubMed
-
- Dobrovolny R, Dvorakova L, Ledvinova J.et al Relationship between X‐inactivation and clinical involvement in Fabry heterozygotes. Eleven novel mutations in the α‐galactosidase A gene in the Czech and Slovak population. J Mol Med 20053647–654. - PubMed